Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Local Feasibility Study on Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Patients Operated Upon Colon Cancer Stage Dukes' C

NCT00671996 is registered in ClinicalTrials.gov with Egetis Therapeutics as lead sponsor.

NCT NCT00671996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00671996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Local Feasibility Study on Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Patients Operated Upon Colon Cancer Stage Dukes' C
Lead sponsor
Egetis Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2008
Completion date
April 30, 2010
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, colon cancer